Compounded tirzepatide
Sold by DrBrainRx · Injection, vial · every compounded tirzepatide record
What you actually pay
Per month
$274
| Medication · Homepage hero/table price (CONTRADICTS product page) | $249 |
|---|---|
| Required membership | $25 |
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Monthly Flex (product page, current) “Tirzepatide Vial Online | Compounded Tirzepatide $299/mo” | Per month$299 | Charged today$299 |
| Homepage hero/table price (CONTRADICTS product page) “Tirzepatide (up to 15mg) $249” | Per month$249 | Charged today$249 |
We earn nothing from this link. DrBrainRx has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| States | 21 states: California, Florida, Kentucky, Maine, Massachusetts, Michigan, Minnesota, Montana, Nevada, New Hampshire, New York, Ohio, Rhode Island, South Carolina, Texas, Utah, Wyoming, Colorado, North Carolina, Indiana, and Nebraska |
|---|---|
| Prescriber | Asynchronous review |
| Cancellation | “Can I cancel anytime? Yes. There are no contracts or cancellation fees. You can cancel your membership anytime through your patient portal—your access continues until the end of your billing cycle.” |
| Membership | Required. $25 per month. “How does the membership work? Your membership covers your ongoing medical care, not the cost of medication. ... $25 / month → Compounded Track (GLP-1s, peptides, Sexy Brain treatments) $99 / month → Brand-Name Track (Wegovy®, Ozempic®, Mounjaro®, Zepbound™ via Lilly Direct or TrumpRx) Medication costs are separate and vary by treatment.” |
Not yet checked: pharmacy and consult fee.
Recorded from drbrainrx.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.